Table 1 Patients’ characteristics
From: Predictors of mortality among patients with type 2 diabetes in Jordan
N = 957 | |
|---|---|
Patients characteristics | |
Age, years | 60.99 ± 0.37 |
Male gender | 482 (50.40) |
BMI (Kg/m2), n = 171 | 32.33 ± 1.49 |
Hx of hypertension | 789 (82.44) |
Hx of heart failure | 99 (10.35) |
Hx of CAD | 470 (49.11) |
Hx of PAD | 38 (3.97) |
Hx of stroke/TIA | 119 (12.43) |
Hx of VTE | 21 (2.19) |
Hx of AF | 47 (4.91) |
Hx of CKD | 115 (12.02) |
Hx of AKI | 163 (19.47) |
Dialysis | 24 (2.50) |
Hx of COPD | 29 (3.03) |
Diabetes mellitus | |
Type 2 | 957 (100.0) |
Diabetic nephropathy | 41 (4.28) |
DKA | 12 (1.43) |
Controlled DM, HbA1c < 7% | 63 (6.65) |
Duration of DM, yrs. | 7.93 ± 0.21 |
NA | 42 (4.38) |
Hx of smoking | |
Current smoking | 149 (15.56) |
X smoker | 76 (7.94) |
NA | 424 (44.30) |
Mortality | 97 (10.14) |
Lab tests (mg/dl) | |
Low Density Lipoprotein (LDL) | 134.82 ± 2.17 |
High Density Lipoprotein (HDL) | 42.09 ± 0.64 |
Triglyceride | 267.77 ± 8.29 |
Total cholesterol (Tch) | 207.04 ± 2.52 |
Fasting plasma glucose | 265.58 ± 3.71 |
HbA1c % (mmole/mole) | 10.19 ± 0.078 |
Creatinine level (mg/dl) | 1.59 ± 0.060 |
Microalbuminuria | 304 (31.77) |
Macroalbuminuria | 154 (16.11) |
Echocardiographic data | |
Left ventricular ejection fraction (LVEF), % | 55.13 ± 0.003 |
atrial size, cm | 3.88 ± 0.0175 |
Use of medications, n (%) | |
ACEIs/ARBs | 741(77.43) |
Aldosterone antagonists | 80 (8.35) |
Thiazide diuretics | 350 (36.61) |
Loop diuretics | 372 (38.87) |
Beta blockers | 693 (72.41) |
Digoxin | 67 (7.00) |
Statins | 818 (85.47) |
Oral Hypoglycemic drugs | 926 (96.76) |
Insulin | 604 (63.11) |
Aspirin | 793 (82.86) |